Genmab A/S

Company Announcement COPENHAGEN, Denmark; November 15, 2022 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 57,442 shares as a consequence of the exercise of employee warrants. The increase is effected without any…

Company Announcement COPENHAGEN, Denmark; November 14, 2022 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data…

November 9, 2022 Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2022 Highlights Genmab revenue increased 60% compared to the first nine months of 2021, to DKK 9,368 millionGenmab improves its 2022…